Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Pierre Césaro »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pierre Charpentier < Pierre Césaro < Pierre Debat  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000206 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
000550 (1999) Patrick Chariot [France] ; Pierre Brugières [France] ; Marie-Christine Eliezer-Vanerot [France] ; Christian Gény [France] ; Michel Binaghi [France] ; Pierre Césaro [France]Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Humans
1Administration, Sublingual
1Adult
1Antioxidants (therapeutic use)
1Antiparkinson Agents (administration & dosage)
1Apomorphine (administration & dosage)
1Case study
1Chorea
1Chorea (complications)
1Chorea (diagnosis)
1Chorea (drug therapy)
1Coenzyme Q10
1Coenzymes
1Cross-Over Studies
1DNA Mutational Analysis
1DNA, Mitochondrial (genetics)
1Dopamine agonist
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Drug Administration Routes
1Etiology
1Exploration
1Fluctuations
1France
1Functional Laterality (physiology)
1Grey matter
1Human
1Leber hereditary optic neuropathy
1Leber optic neuropathy
1Logistic Models
1MRI
1Magnetic Resonance Imaging
1Male
1Mitochondria
1Nervous system diseases
1Nuclear magnetic resonance imaging
1Optic Atrophies, Hereditary (complications)
1Optic nerve
1Optic neuropathy
1Parkinson Disease (drug therapy)
1Parkinson disease
1Parkinson's disease
1Piribedil
1Piribedil (administration & dosage)
1Placebo
1Proportional Hazards Models
1S90049
1Severity of Illness Index
1Single dose
1Subthalamic Nucleus (pathology)
1Subthalamic nucleus
1Treatment
1Treatment Outcome
1Ubiquinone (analogs & derivatives)
1Ubiquinone (therapeutic use)
1Vitamins (therapeutic use)
1apomorphine
1dopamine agonist
1motor fluctuations
1piribedil

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Pierre Césaro" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Pierre Césaro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Pierre Césaro
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024